|
| 38043562 | Relapse in clinically stable adult patients with schizophrenia or schizoaffective disorder: evidence-based criteria derived by equipercentile linking and diagnostic test accuracy meta-analysis. | Lancet Psychiatry | 2024 |
| 36915909 | The Effect of Longer Dosing Intervals for Long-Acting Injectable Antipsychotics on Outcomes in Schizophrenia. | | 2023 |
| 35835710 | Clinical and computational speech measures are associated with social cognition in schizophrenia spectrum disorders. | Schizophrenia Research | 2023 |
| 35510505 | Efficacy and safety/tolerability of antipsychotics in the treatment of adult patients with major depressive disorder: a systematic review and meta-analysis. | Psychological Medicine | 2023 |
| 35634965 | Relapse prevention through health technology program reduces hospitalization in schizophrenia. | Psychological Medicine | 2023 |
| 37609149 | Replication of a neuroimaging biomarker for striatal dysfunction in psychosis. | | 2023 |
| 37924833 | Efficacy and safety of TV-46000, a long-acting, subcutaneous, injectable formulation of risperidone, for schizophrenia: a randomised clinical trial in the USA and Bulgaria. | | 2023 |
| 37344763 | Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: treatment goals and approaches to functional recovery. | | 2023 |
| 36586617 | Validation of the Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT) questionnaire for adults. | J Affect Disord | 2023 |
| 36959874 | Changes in Clinical Management of Patients with Schizophrenia Treated with Long-Acting Injectable Antipsychotics (LAIs), Including Telepsychiatry Use, During the COVID-19 Pandemic. | Neuropsychiatr Dis Treat | 2023 |
| 36895432 | The place of long-acting injectable antipsychotics in the treatment of schizophrenia. | | 2023 |
| 36580106 | Clozapine once- versus multiple-daily dosing: a two-center cross-sectional study, systematic review and meta-analysis. | | 2023 |
| 36640403 | The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de-risk trial programmes of novel agents. | World Psychiatry | 2023 |
| 37074300 | Treatment Journey From Diagnosis to the Successful Implementation of a Long-Acting Injectable Antipsychotic Agent in Young Adults With Schizophrenia. | | 2023 |
| 37261669 | Early Non-Response to Antipsychotic Treatment in Schizophrenia: A Systematic Review and Meta-Analysis of Evidence-Based Management Options. | | 2023 |
| 36946605 | Olanzapine/Samidorphan in Young Adults With Schizophrenia, Schizophreniform Disorder, or Bipolar I Disorder Who Are Early in Their Illness: Results of the Randomized, Controlled ENLIGHTEN-Early Study. | | 2023 |
| 36945577 | Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: Treatment goals and approaches to functional recovery. | | 2023 |
| 36752713 | Early versus late administration of long-acting injectable antipsychotic agents among patients with newly diagnosed schizophrenia: an analysis of a commercial claims database. | | 2023 |
| 36634452 | Longitudinal study of inflammation and relapse in schizophrenia. | | 2023 |
| 36943247 | Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group. | Schizophr Bull | 2023 |
| 36791360 | Predictors for Initiation of Atypical Long-Acting Injectable Antipsychotic Agents in a Commercial Claims Cohort of Individuals With Early-Phase Schizophrenia. | | 2023 |
| 37353255 | The use of long-acting injectables in early-phase schizophrenia. | | 2023 |
| 37503088 | Replication of a neuroimaging biomarker for striatal dysfunction in psychosis. | | 2023 |
| 37292182 | A Patient-Clinician Discussion of Current Challenges in Schizophrenia Part 2: Negative Symptoms in Schizophrenia [Podcast]. | | 2023 |
| 37292181 | A Patient-Clinician Discussion of Current Challenges in Schizophrenia Part 1: Addressing Daily Functioning and Cognitive Impairments Associated with Schizophrenia [Podcast]. | Neuropsychiatr Dis Treat | 2023 |
| 37161690 | A systematic review of digital interventions for smoking cessation in patients with serious mental illness. | Psychol Med | 2023 |
| 35052001 | Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels. | Pharmacopsychiatry | 2022 |
| 35394202 | An international clozapine titration guideline to increase its safety and move forward on the route started by German-speaking psychiatrists in the 1960s. | European Archives of Psychiatry and Clinical Neuroscience | 2022 |
| 36099402 | A New Treatment Paradigm: Targeting Trace Amine-Associated Receptor 1 (TAAR1) in Schizophrenia. | Journal of Clinical Psychopharmacology | 2022 |
| 35647489 | The Reintegration Journey Following A Psychiatric Hospitalization: Examining the Role of Social Technologies. | Proceedings of the ACM on Human-Computer Interaction | 2022 |
| 36355414 | Digital Technology in Psychiatry: Survey Study of Clinicians. | JMIR Formative Research | 2022 |
| 36222818 | A Digital Intervention Using Daily Financial Incentives to Increase Medication Adherence in Severe Mental Illness: Single-Arm Longitudinal Pilot Study. | JMIR Mental Health | 2022 |
| 35695172 | Prescribing clozapine in the UK: Quality improvement issues identified by clinical audit. | Journal of Psychopharmacology | 2022 |
| 35635994 | Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases. | European Neuropsychopharmacology | 2022 |
| 35743326 | MDMA for the Treatment of Negative Symptoms in Schizophrenia. | Journal of Clinical Medicine | 2022 |
| 35689478 | Outcomes During and After Early Intervention Services for First-Episode Psychosis: Results Over 5 Years From the RAISE-ETP Site-Randomized Trial. | Schizophr Bull | 2022 |
| 35372430 | Psychotropic Medication Use Is Associated With Greater 1-Year Incidence of Dementia After COVID-19 Hospitalization. | Front Med (Lausanne) | 2022 |
| 35427873 | Post-acute college student satisfaction with telepsychiatry during the COVID-19 pandemic. | Journal of Psychiatric Research | 2022 |
| 36070576 | Reasons for Antipsychotic Treatment Switch: A Systematic Retrospective Review of Prescription Records and Prescriber Notes. | Journal of Clinical Psychiatry | 2022 |
| 35417282 | Pharmacovigilance approaches to study rare and very rare side-effects: the example of clozapine-related DiHS/DRESS syndrome. | Expert Opinion on Drug Safety | 2022 |
| 35664474 | Digital Strategies to Accelerate Help-Seeking in Youth With Psychiatric Concerns in New York State. | Frontiers in Psychiatry | 2022 |
| 36400895 | Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database. | Drug Safety | 2022 |
| 36449471 | Impact-Tardive Dyskinesia (Impact-TD) Scale: A Clinical Tool to Assess the Impact of Tardive Dyskinesia. | Journal of Clinical Psychiatry | 2022 |
| 36317338 | Distinguishing the Effects of Lead-Time Bias and Duration of Untreated Psychosis. | Am J Psychiatry | 2022 |
| 36115192 | Efficacy and safety of Lu AF35700 in treatment-resistant schizophrenia: A randomized, active-controlled trial with open-label extension. | Schizophrenia Research | 2022 |
| 35660967 | Validation of a novel Psychosis-Implicit Association Test (P-IAT) as a diagnostic support tool. | Psychiatry Res | 2022 |
| 36714170 | Burnout and the Quantified Workplace: Tensions around Personal Sensing Interventions for Stress in Resident Physicians. | Proc ACM Hum Comput Interact | 2022 |
| 36583932 | Cross-Platform Detection of Psychiatric Hospitalization via Social Media Data: Comparison Study. | | 2022 |
| 36528376 | Emraclidine, a novel positive allosteric modulator of cholinergic M4 receptors, for the treatment of schizophrenia: a two-part, randomised, double-blind, placebo-controlled, phase 1b trial. | | 2022 |
| 34183210 | Striatal functional connectivity in psychosis relapse: A hypothesis generating study. | Schizophrenia Research | 2022 |